What was the market valuation of the UK stem cell-therapy market in 2024?

The market valuation was $5.85 Million in 2024. Read More

What is the projected market valuation for the UK stem cell-therapy market by 2035?

The projected valuation for 2035 is $22.8 Million. Read More

What is the expected CAGR for the UK stem cell-therapy market during the forecast period 2025 - 2035?

The expected CAGR is 13.16% during the forecast period 2025 - 2035. Read More

Which application segments are included in the UK stem cell-therapy market?

The application segments include Cell Therapy, Tissue Engineering, Regenerative Medicine, and Gene Therapy. Read More

What are the projected valuations for the Cell Therapy segment by 2035?

The projected valuation for the Cell Therapy segment is expected to reach $5.5 Million by 2035. Read More

What is the expected valuation for Mesenchymal Stem Cells by 2035?

The expected valuation for Mesenchymal Stem Cells is projected to be $12.0 Million by 2035. Read More

Who are the key players in the UK stem cell-therapy market?

Key players include Mesoblast Limited, Athersys Inc, Osiris Therapeutics Inc, and Cynata Therapeutics Limited. Read More

What are the primary sources of stem cells in the UK market?

Primary sources of stem cells include Bone Marrow, Cord Blood, Adipose Tissue, and Peripheral Blood. Read More

What is the projected valuation for Cord Blood as a source of stem cells by 2035?

The projected valuation for Cord Blood is expected to reach $8.5 Million by 2035. Read More

UK Stem Cell Therapy Market

Q: What types of stem cells are prominent in the UK market?

Prominent types of stem cells include Embryonic Stem Cells, Adult Stem Cells, Induced Pluripotent Stem Cells, and Mesenchymal Stem Cells. Read More

ID: MRFR/Pharma/51401-HCR

200 Pages

Rahul Gotadki

Last Updated: February 06, 2026

UK Stem Cell Therapy Market Research Report: Size, Share, Trend Analysis By Applications (Orthopedic, Cardiovascular, Neurological, Dermatological, Dental), By Types of Stem Cells (Embryonic Stem Cells, Adult Stem Cells, Induced Pluripotent Stem Cells, Mesenchymal Stem Cells), By Therapeutic Area (Regenerative Medicine, Cancer Treatment, Autoimmune Diseases, Genetic Disorders), and By Procedure Type (Surgical Procedures, Non-surgical Procedures) - Growth Outlook & Industry Forecast 2025 To 2035

UK Stem Cell Therapy Market

Market Size

Forecast Period2025 - 2035

CAGR (2025 - 2035)13.16%

2024 Market Size$ 5.85 Million

2025 Market Size$ 6.62 Million

2035 Market Size$ 22.8 Million

Key Players

Mesoblast Limited

Athersys Inc

Osiris Therapeutics Inc

Cynata Therapeutics Limited

StemCells Inc

Regenexx

Trends

Regulatory Developments
Technological Advancements
Increased Collaboration

Opportunities

Advancements in Regulatory Frameworks
Rising Prevalence of Chronic Diseases
Investment in Research and Development

Summary Table of Contents Segmentation Download PDF

Certified Researchers

Customize Report

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Healthcare, BY Application (USD Million)
  1. 4.1.1 Cell Therapy
  2. 4.1.2 Tissue Engineering
  3. 4.1.3 Regenerative Medicine
  4. 4.1.4 Gene Therapy
2. 4.2 Healthcare, BY Type of Stem Cells (USD Million)
  1. 4.2.1 Embryonic Stem Cells
  2. 4.2.2 Adult Stem Cells
  3. 4.2.3 Induced Pluripotent Stem Cells
  4. 4.2.4 Mesenchymal Stem Cells
3. 4.3 Healthcare, BY Source of Stem Cells (USD Million)
  1. 4.3.1 Bone Marrow
  2. 4.3.2 Cord Blood
  3. 4.3.3 Adipose Tissue
  4. 4.3.4 Peripheral Blood
4. 4.4 Healthcare, BY End User (USD Million)
  1. 4.4.1 Hospitals
  2. 4.4.2 Research Institutions
  3. 4.4.3 Pharmaceutical Companies
  4. 4.4.4 Biotechnology Companies
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Healthcare
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Mesoblast Limited (AU)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Athersys Inc (US)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Osiris Therapeutics Inc (US)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 Cynata Therapeutics Limited (AU)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 StemCells Inc (US)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 Regenexx (US)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 Tigenix (BE)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 Kite Pharma Inc (US)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
  9. 5.2.9 Vericel Corporation (US)
    1. 5.2.9.1 Financial Overview
    2. 5.2.9.2 Products Offered
    3. 5.2.9.3 Key Developments
    4. 5.2.9.4 SWOT Analysis
    5. 5.2.9.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 UK MARKET ANALYSIS BY APPLICATION
3. 6.3 UK MARKET ANALYSIS BY TYPE OF STEM CELLS
4. 6.4 UK MARKET ANALYSIS BY SOURCE OF STEM CELLS
5. 6.5 UK MARKET ANALYSIS BY END USER
6. 6.6 KEY BUYING CRITERIA OF HEALTHCARE
7. 6.7 RESEARCH PROCESS OF MRFR
8. 6.8 DRO ANALYSIS OF HEALTHCARE
9. 6.9 DRIVERS IMPACT ANALYSIS: HEALTHCARE
10. 6.10 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
11. 6.11 SUPPLY / VALUE CHAIN: HEALTHCARE
12. 6.12 HEALTHCARE, BY APPLICATION, 2024 (% SHARE)
13. 6.13 HEALTHCARE, BY APPLICATION, 2024 TO 2035 (USD Million)
14. 6.14 HEALTHCARE, BY TYPE OF STEM CELLS, 2024 (% SHARE)
15. 6.15 HEALTHCARE, BY TYPE OF STEM CELLS, 2024 TO 2035 (USD Million)
16. 6.16 HEALTHCARE, BY SOURCE OF STEM CELLS, 2024 (% SHARE)
17. 6.17 HEALTHCARE, BY SOURCE OF STEM CELLS, 2024 TO 2035 (USD Million)
18. 6.18 HEALTHCARE, BY END USER, 2024 (% SHARE)
19. 6.19 HEALTHCARE, BY END USER, 2024 TO 2035 (USD Million)
20. 6.20 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 UK MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY APPLICATION, 2025-2035 (USD Million)
  2. 7.2.2 BY TYPE OF STEM CELLS, 2025-2035 (USD Million)
  3. 7.2.3 BY SOURCE OF STEM CELLS, 2025-2035 (USD Million)
  4. 7.2.4 BY END USER, 2025-2035 (USD Million)
2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.3.1
1. 7.4 ACQUISITION/PARTNERSHIP
7.4.1

Certified Researchers

Customize Report

UK Stem Cell Therapy Market Segmentation

UK Stem Cell Therapy Market By Application (USD Million, 2025-2035)

Cell Therapy
Tissue Engineering
Regenerative Medicine
Gene Therapy

UK Stem Cell Therapy Market By Type of Stem Cells (USD Million, 2025-2035)

Embryonic Stem Cells
Adult Stem Cells
Induced Pluripotent Stem Cells
Mesenchymal Stem Cells

UK Stem Cell Therapy Market By Source of Stem Cells (USD Million, 2025-2035)

Bone Marrow
Cord Blood
Adipose Tissue
Peripheral Blood

UK Stem Cell Therapy Market By End User (USD Million, 2025-2035)

Hospitals
Research Institutions
UK Stem Cell Therapy Market Companies
Biotechnology Companies

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”